ROBERT WOODROME: Open Payments
NPI 1265476998 · SPLENDORA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 46 payments from 13 companies in 2025. Trend: 2023 $3,127 · 2024 $1,072 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $487 |
| ABBVIE INC. | 17 | $298 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Exact Sciences Corporation | 3 | $68 |
| Viatris Specialty LLC | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Dexcom, Inc. | 2 | $40 |
| Tactile Systems Technology Inc | 1 | $40 |
| PFIZER INC. | 2 | $39 |
| Novo Nordisk Inc | 1 | $27 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, CAPLYTA, FARXIGA, Cologuard Collection Kit, YUPELRI, REXULTI.
Industry payments across TX — which companies pay providers there.
